mortality/aging
• death within 6-7 months of tamoxifen treatment
|
respiratory system
• small cell lung tumors 5-6 months after tamoxifen treatment in 4 of 32 mice examined, all with pulmonary neuroendocrine cells hyperplasia as well
|
• pulmonary neuroendocrine cells hyperplasia 5-6 months after tamoxifen treatment in 16 of 32 mice examined
• increased proliferation of pulmonary neuroendocrine cells
|
neoplasm
• all mice develop thyroid tumors
|
• small cell lung tumors 5-6 months after tamoxifen treatment in 4 of 32 mice examined, all with pulmonary neuroendocrine cells hyperplasia as well
|
endocrine/exocrine glands
• all mice develop thyroid tumors
|